Paid Clinical Trials Michigan
Discover 1,955 paid clinical trials in Michigan. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyPancreatic Cancer Early Detection Consortium
Sponsor:
Arbor Research Collaborative for Health
Location:
Code:
NCT04970056
Conditions
Pancreas Cancer
Pancreas Cyst
Pancreatic Ductal Adenocarcinoma
Genetic Predisposition
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Accepted
Development of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMTDevelopment of Charcot Marie Tooth Disease (CMT) Pediatric Scale for Children With CMT
Sponsor:
University of Iowa
Location:
Code:
NCT01203085
Conditions
Charcot Marie Tooth Disease
Eligibility Criteria
Sex: All
Age: 0 - 21
Healthy Volunteers: Not accepted
FT825/ONO-8250 & Monoclonal AntibodiesFT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, with or Without Monoclonal Antibodies in Advanced Solid Tumors
Sponsor:
Fate Therapeutics
Location:
Code:
NCT06241456
Conditions
Advanced Solid Tumor
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
FT825
Fludarabine
Cyclophosphamide
Bendamustine
Docetaxel
RRMMMMRC Horizon One Adaptive Platform Trial Evaluating Therapies in RRMM
Sponsor:
Multiple Myeloma Research Consortium
Location:
Code:
NCT06171685
Conditions
Relapse Multiple Myeloma
Refractory Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Teclistamab Monotherapy
Teclistamab
Neoadjuvant Chemotherapy vs. ChemoradiotherapyNeoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Sponsor:
Canadian Cancer Trials Group
Location:
Code:
NCT06205485
Conditions
Rectal Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Leucovorin
Oxaliplatin
Fluoruracil
Capecitabine
Radiation
Interested in new trials?
Get alerts for new trials in your area by subscribing now
BLU-263(HARBOR) Study to Evaluate Efficacy and Safety of BLU-263 Versus Placebo in Patients With Indolent Systemic Mastocytosis
Sponsor:
Blueprint Medicines Corporation
Location:
Code:
NCT04910685
Conditions
Indolent Systemic Mastocytosis
Monoclonal Mast Cell Activation Syndrome
Smoldering Systemic Mastocytosis
Eligibility Criteria
Sex: All
Age: 16+
Healthy Volunteers: Not accepted
Interventions
Elenestinib
Placebo
Selinexor & ChemotherapySelinexor Plus Combination Chemotherapy in Treating Patients With Advanced B Cell Non-Hodgkin Lymphoma
Sponsor:
Barbara Ann Karmanos Cancer Institute
Location:
Code:
NCT03147885
Conditions
Diffuse Large B-Cell Lymphoma
Recurrent B-Cell Non-Hodgkin Lymphoma
Recurrent Extranodal Marginal Zone Lymphoma
Recurrent Follicular Lymphoma
Recurrent Indolent Adult Non-Hodgkin Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Selinexor
OfatumumabPharmacokinetics, Pharmacodynamics, Safety and Tolerability of a New Maintenance Dosing Regimen of Ofatumumab
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT06869785
Conditions
Relapsing Multiple Sclerosis (RMS)
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Ofatumumab approved dose
Ofatumumab new dose
Operative vs. Non-OperativeMulti-Center Adolescent Clavicle Fracture Trial: Operative Vs. Non-Operative Treatment
Sponsor:
Boston Children's Hospital
Location:
Code:
NCT04250415
Conditions
Clavicle Fracture
Eligibility Criteria
Sex: All
Age: 10 - 18
Healthy Volunteers: Not accepted
Interventions
Surgery
DWN12088Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
Sponsor:
Daewoong Pharmaceutical Co. LTD.
Location:
Code:
NCT05389215
Conditions
Idiopathic Pulmonary Fibrosis
Eligibility Criteria
Sex: All
Age: 40+
Healthy Volunteers: Not accepted
Interventions
DWN12088
Placebo